eFFECTOR Therapeutics- Warrants (26/08/2026) Net Tangible Assets

As of the most recent data (June 2026), EFTRW shows a net tangible assets of $220M. That compares with $210M in the prior-year period — up 3.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EFTRW's net tangible assets is now $220M (was $210M) — a 3.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether eFFECTOR Therapeutics- Warrants (26/08/2026) is outperforming or lagging.

Tracking EFTRW's net tangible assets over time shows whether eFFECTOR Therapeutics- Warrants (26/08/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $220M That compares with $210M in the prior-year period — up 3.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has eFFECTOR Therapeutics- Warrants (26/08/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $220M) with ownership activity and broader fundamentals.

eFFECTOR Therapeutics- Warrants (26/08/2026)'s net tangible assets is $220M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.